Evidence map›Paper›PMID 37118723›Full record

ArticleBMC medical ethics2023

Project DECIDE, part II: decision-making places for people with dementia in Alzheimer's disease: supporting advance decision-making by improving person-environment fit.

Janina Florack, Christina Abele, Stefanie Baisch, Simon Forstmeier, Daniel Garmann, Martin Grond, Ingmar Hornke, Tarik Karakaya, Jonas Karneboge, Boris Knopf and 11 more

Open access · goldAbstract read
In one paragraph

Article in BMC medical ethics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 5 institutions in 1 country.

Janina FlorackFaculty V: School of Life Sciences, Department of Psychology, Psychological Aging Research (PAR), University of Siegen, Adolf-Reichwein-Str. 2a, 57068, Siegen, Germany. janina.florack@uni-siegen.de.
Christina AbeleFaculty V: School of Life Sciences, Department of Psychology, Psychological Aging Research (PAR), University of Siegen, Adolf-Reichwein-Str. 2a, 57068, Siegen, Germany.
Stefanie BaischFaculty V: School of Life Sciences, Department of Psychology, Psychological Aging Research (PAR), University of Siegen, Adolf-Reichwein-Str. 2a, 57068, Siegen, Germany.
Simon ForstmeierFaculty V: School of Life Sciences, Department of Psychology, Psychological Aging Research (PAR), University of Siegen, Adolf-Reichwein-Str. 2a, 57068, Siegen, Germany.
Daniel GarmannFaculty V: School of Life Sciences, Department of Psychology, Psychological Aging Research (PAR), University of Siegen, Adolf-Reichwein-Str. 2a, 57068, Siegen, Germany.
Martin GrondKlinikum Siegen, Siegen, Germany.
Ingmar HornkeWürdezentrum, Frankfurt Am Main, Germany.
Tarik KarakayaUniversity Hospital Frankfurt, Frankfurt Am Main, Germany.
Jonas KarnebogeFaculty V: School of Life Sciences, Department of Psychology, Psychological Aging Research (PAR), University of Siegen, Adolf-Reichwein-Str. 2a, 57068, Siegen, Germany.
Boris KnopfWürdezentrum, Frankfurt Am Main, Germany.
Gregor LindlFaculty V: School of Life Sciences, Department of Psychology, Psychological Aging Research (PAR), University of Siegen, Adolf-Reichwein-Str. 2a, 57068, Siegen, Germany.
Tanja MüllerFaculty V: School of Life Sciences, Department of Psychology, Psychological Aging Research (PAR), University of Siegen, Adolf-Reichwein-Str. 2a, 57068, Siegen, Germany.
Frank OswaldGoethe University Frankfurt, Frankfurt Am Main, Germany.
Nathalie PfeifferFaculty V: School of Life Sciences, Department of Psychology, Psychological Aging Research (PAR), University of Siegen, Adolf-Reichwein-Str. 2a, 57068, Siegen, Germany.
David PrvulovicUniversity Hospital Frankfurt, Frankfurt Am Main, Germany.
Aoife PothFaculty V: School of Life Sciences, Department of Psychology, Psychological Aging Research (PAR), University of Siegen, Adolf-Reichwein-Str. 2a, 57068, Siegen, Germany.
Andreas ReifUniversity Hospital Frankfurt, Frankfurt Am Main, Germany.
Irene SchmidtmannUniversity Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Anna Theile-SchürholzFaculty V: School of Life Sciences, Department of Psychology, Psychological Aging Research (PAR), University of Siegen, Adolf-Reichwein-Str. 2a, 57068, Siegen, Germany.
Heiko UllrichKlinikum Siegen, Siegen, Germany.
Julia HaberstrohFaculty V: School of Life Sciences, Department of Psychology, Psychological Aging Research (PAR), University of Siegen, Adolf-Reichwein-Str. 2a, 57068, Siegen, Germany.
University of Siegen · DEGoethe University Frankfurt · DEUniversity Hospital Frankfurt · DEJohannes Gutenberg University Mainz · DEUniversity Medical Center of the Johannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe UN Convention on the Rights of Persons with Disabilities, and the reformed guardianship law in Germany, require that persons with a disability, including people with dementia in Alzheimer's disease (PwAD), are supported in making self-determined decisions. This support is achieved through communication. While content-related communication is a deficit of PwAD, relational aspects of communication are a resource. Research in supported decision-making (SDM) has investigated the effectiveness of different content-related support strategies for PwAD but has only succeeded in improving understanding, which, although one criterion of capacity to consent, is not sufficient to ensure overall capacity to consent. The aim of the 'spatial intervention study' of the DECIDE project is to examine an innovative resource-oriented SDM approach that focuses on relational aspects. We hypothesise that talking to PwAD in their familiar home setting (as opposed to a clinical setting) will reduce the complexity of the decision-making process and enhance overall capacity to consent.

methodsPeople with a suspected or confirmed diagnosis of dementia in Alzheimer's disease will be recruited from two memory clinics (N = 80). We will use a randomised crossover design to investigate the intervention effect of the decision-making place on capacity to consent. Besides reasoning capacity, which is part of overall capacity to consent and will be the primary outcome, various secondary outcomes (e.g., other aspects of capacity to consent, subjective task complexity, decisional conflict) and suspected moderating or mediating variables (e.g., meaning of home, demographic characteristics) will be assessed. DISCUSSION: The results of the study will be used to develop a new SDM strategy that is based on relational resources for PwAD. If a change in location achieves the anticipated improvement in capacity to consent, future research should focus on implementing this SDM strategy in a cost-effective manner in clinical practice.

trial registrationDRKS00030799 .

Indexed as

Alzheimer DiseaseDecision MakingGermanyHumansAlzheimer’s diseaseAutonomyBelongingCapacity to consentDementiaMeaning of homeMemory clinicPatient empowermentSupported decision making

Identifiers

PMID37118723
PMCPMC10148477
OpenAlexW4367297228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.